Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-12-007996
Filing Date
2012-08-09
Accepted
2012-08-09 07:01:00
Documents
13
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nby_10q-063012.htm 10-Q 936662
2 EXHIBIT 10.1 ex10-1.htm EX-10.1 169077
3 EXHIBIT 10.2 ex10-2.htm EX-10.2 39536
4 EXHIBIT 31.1 ex31-1.htm EX-31.1 11608
5 EXHIBIT 31.2 ex31-2.htm EX-31.2 11394
6 EXHIBIT 32.1 ex32-1.htm EX-32.1 5717
7 EXHIBIT 32.2 ex32-2.htm EX-32.2 5806
  Complete submission text file 0001437749-12-007996.txt   6420788

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT nby-20120630.xml EX-101.INS 1105853
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nby-20120630.xsd EX-101.SCH 40179
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nby-20120630_cal.xml EX-101.CAL 32171
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nby-20120630_def.xml EX-101.DEF 244783
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nby-20120630_lab.xml EX-101.LAB 314038
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nby-20120630_pre.xml EX-101.PRE 248999
Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: CA | Fiscal Year End: 0120
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 121018458
SIC: 2834 Pharmaceutical Preparations